Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and ...

FirstHealth of the Carolinas will offer free lung cancer screenings using its mobile Lung Bus at FirstHealth Lee Campus located at 2919 Beechtree Drive in Sanford from 8:30 a.m. to 12:30 p.m. on ...

Cambridge: AstraZeneca has announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval ...

Rybrevant plus chemotherapy improved response and delayed disease progression for patients with EGFR-mutated non–small cell ...

When small-cell lung cancer (SCLC) has spread to distant parts of the body, it’s classified as extensive-stage, which applies ...

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

Lung cancer is a big problem. It claims many lives each year. Around 160,000 people die annually in the US. This figure is ...

FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response ...

AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) Datroway has been granted accelerated approval ...

People living with HIV are at an increased risk for lung cancer, with some studies estimating risk to be 1.5 to 3-fold higher ...

Carbon Ultrafine Particles Accelerate Lung Cancer Progression; Tuesday, November 15, 2022. Emphysema More Common in Marijuana Smokers Than Cigarette Smokers; Tuesday, November 8, 2022.

DATROWAY® Approved in the U.S. as First TROP2 Directed Therapy for Patients with Previously Treated Advanced EGFR-Mutated Non ...